Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Antibody-Drug Conjugate market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 7.3% during the forecast period.
This report presents the market size and development trends by detailing the Antibody-Drug Conjugate market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Antibody-Drug Conjugate market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Antibody-Drug Conjugate industry and will help you to build a panoramic view of the industrial development.
Antibody-Drug Conjugate Market, By Type:
Type 1
Type 2
Type 3
Antibody-Drug Conjugate Market, By Application:
End-User 1
End-User 2
End-User 3
Some of the leading players are as follows:
Amgen
Roche
Boehringer Ingelheim
Pfizer
AstraZeneca
Eli Lilly
Servier
Janssen Biotech
GlaxoSmithKline
Bayer
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Antibody-Drug Conjugate Market: Technology Type Analysis
-
4.1 Antibody-Drug Conjugate Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Antibody-Drug Conjugate Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Type 1
4.3.2 Type 2
4.3.3 Type 3
5 Antibody-Drug Conjugate Market: Product Analysis
-
5.1 Antibody-Drug Conjugate Product Market Share Analysis, 2018 & 2026
-
5.2 Antibody-Drug Conjugate Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Antibody-Drug Conjugate Market: Application Analysis
-
6.1 Antibody-Drug Conjugate Application Market Share Analysis, 2018 & 2026
-
6.2 Antibody-Drug Conjugate Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 End-User 1
6.3.2 End-User 1
6.3.3 End-User 3
7 Antibody-Drug Conjugate Market: Regional Analysis
-
7.1 Antibody-Drug Conjugate Regional Market Share Analysis, 2018 & 2026
-
7.2 Antibody-Drug Conjugate Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Amgen
9.1.1 Amgen Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Roche
9.2.1 Roche Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Boehringer Ingelheim
9.3.1 Boehringer Ingelheim Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Pfizer
9.4.1 Pfizer Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 AstraZeneca
9.5.1 AstraZeneca Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Eli Lilly
9.6.1 Eli Lilly Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Servier
9.7.1 Servier Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Janssen Biotech
9.8.1 Janssen Biotech Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 GlaxoSmithKline
9.9.1 GlaxoSmithKline Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Bayer
9.10.1 Bayer Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
The List of Tables and Figures (Totals 99 Figures and 127 Tables)
Figure Type 1 Antibody-Drug Conjugate market, 2015 - 2026 (USD Million)
Figure Type 2 Antibody-Drug Conjugate market, 2015 - 2026 (USD Million)
Figure Type 3 Antibody-Drug Conjugate market, 2015 - 2026 (USD Million)
Figure End-User 1 market, 2015 - 2026 (USD Million)
Figure End-User 2 market, 2015 - 2026 (USD Million)
Figure End-User 3 market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Antibody-Drug Conjugate market, by country, 2015 - 2026 (USD Million)
-
Table North America Antibody-Drug Conjugate market, by type, 2015 - 2026 (USD Million)
-
Table North America Antibody-Drug Conjugate market, by product, 2015 - 2026 (USD Million)
-
Table North America Antibody-Drug Conjugate market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Antibody-Drug Conjugate market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Antibody-Drug Conjugate market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Antibody-Drug Conjugate market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Antibody-Drug Conjugate market, by type, 2015 - 2026 (USD Million)
-
Table Canada Antibody-Drug Conjugate market, by product, 2015 - 2026 (USD Million)
-
Table Canada Antibody-Drug Conjugate market, by application, 2015 - 2026 (USD Million)
-
Table Europe Antibody-Drug Conjugate market, by country, 2015 - 2026 (USD Million)
-
Table Europe Antibody-Drug Conjugate market, by type, 2015 - 2026 (USD Million)
-
Table Europe Antibody-Drug Conjugate market, by product, 2015 - 2026 (USD Million)
-
Table Europe Antibody-Drug Conjugate market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Antibody-Drug Conjugate market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Antibody-Drug Conjugate market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Antibody-Drug Conjugate market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Antibody-Drug Conjugate market, by type, 2015 - 2026 (USD Million)
-
Table Germany Antibody-Drug Conjugate market, by product, 2015 - 2026 (USD Million)
-
Table Germany Antibody-Drug Conjugate market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Antibody-Drug Conjugate market, by type, 2015 - 2026 (USD Million)
-
Table France Antibody-Drug Conjugate market, by product, 2015 - 2026 (USD Million)
-
Table France Antibody-Drug Conjugate market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Antibody-Drug Conjugate market, by type, 2015 - 2026 (USD Million)
-
Table Italy Antibody-Drug Conjugate market, by product, 2015 - 2026 (USD Million)
-
Table Italy Antibody-Drug Conjugate market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Antibody-Drug Conjugate market, by type, 2015 - 2026 (USD Million)
-
Table Spain Antibody-Drug Conjugate market, by product, 2015 - 2026 (USD Million)
-
Table Spain Antibody-Drug Conjugate market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Antibody-Drug Conjugate market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Antibody-Drug Conjugate market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Antibody-Drug Conjugate market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Antibody-Drug Conjugate market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Antibody-Drug Conjugate market, by type, 2015 - 2026 (USD Million)
-
Table China Antibody-Drug Conjugate market, by product, 2015 - 2026 (USD Million)
-
Table China Antibody-Drug Conjugate market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Antibody-Drug Conjugate market, by type, 2015 - 2026 (USD Million)
-
Table Japan Antibody-Drug Conjugate market, by product, 2015 - 2026 (USD Million)
-
Table Japan Antibody-Drug Conjugate market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Antibody-Drug Conjugate market, by type, 2015 - 2026 (USD Million)
-
Table India Antibody-Drug Conjugate market, by product, 2015 - 2026 (USD Million)
-
Table India Antibody-Drug Conjugate market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Antibody-Drug Conjugate market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Antibody-Drug Conjugate market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Antibody-Drug Conjugate market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Antibody-Drug Conjugate market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Antibody-Drug Conjugate market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Antibody-Drug Conjugate market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Antibody-Drug Conjugate market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Antibody-Drug Conjugate market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Antibody-Drug Conjugate market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Antibody-Drug Conjugate market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Antibody-Drug Conjugate market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Antibody-Drug Conjugate market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Antibody-Drug Conjugate market, by application, 2015 - 2026 (USD Million)
-
Table MEA Antibody-Drug Conjugate market, by country, 2015 - 2026 (USD Million)
-
Table MEA Antibody-Drug Conjugate market, by type, 2015 - 2026 (USD Million)
-
Table MEA Antibody-Drug Conjugate market, by product, 2015 - 2026 (USD Million)
-
Table MEA Antibody-Drug Conjugate market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Antibody-Drug Conjugate market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Antibody-Drug Conjugate market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Antibody-Drug Conjugate market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Antibody-Drug Conjugate market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Antibody-Drug Conjugate market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Antibody-Drug Conjugate market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Amgen Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Roche Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Boehringer Ingelheim Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Pfizer Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table AstraZeneca Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Eli Lilly Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Servier Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Janssen Biotech Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table GlaxoSmithKline Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Bayer Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
